Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    mainritsan
Show Display Options
Rank Status Study
1 Active, not recruiting Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab
Condition: ANCA-associated Vasculitides
Interventions: Drug: rituximab;   Drug: Placebo
2 Completed Efficacy Study of Two Treatments in the Remission of Vasculitis
Conditions: Wegener's Granulomatosis,;   Microscopic Polyangiitis
Interventions: Drug: Rituximab;   Drug: Azathioprine
3 Active, not recruiting Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
Conditions: Granulomatosis With Polyangiitis;   Microscopic Polyangiitis;   Renal Limited Forms
Interventions: Drug: Rituximab (Arm B);   Drug: Rituximab (Arm A)

Study has passed its completion date and status has not been verified in more than two years.